Sonoda, Soichiro and Yoshimaru, Koichiro and Yamaza, Haruyoshi and Yuniartha, Ratih and Matsuura, Toshiharu and Yamauchi-Tomoda, Erika and Murata, Sara and Nishida, Kento and Oda, Yoshinao and Ohga, Shouichi and Tajiri, Tasturo and Taguchi, Tomoaki and Yamaza, Takayoshi (2021) Biliary atresia-specific deciduous pulp stem cells feature biliary deficiency. Stem Cell Research and Therapy, 12 (1). ISSN 17576512
Full text not available from this repository. (Request a copy)Abstract
Background: Biliary atresia (BA) is a severe hepatobiliary disease in infants that ultimately results in hepatic failure; however, its pathological mechanism is poorly elucidated. Current surgical options, including Kasai hepatoportoenterostomy and orthotopic liver organ transplantations, are palliative; thus, innovation in BA therapy is urgent. Methods: To examine whether BA-specific post-natal stem cells are feasible for autologous cell source for BA treatment, we isolated from human exfoliated deciduous teeth, namely BA-SHED, using a standard colony-forming unit fibroblast (CFU-F) method and compared characteristics as mesenchymal stem cells (MSCs) to healthy donor-derived control SHED, Cont-SHED. BA-SHED and Cont-SHED were intrasplenically transplanted into chronic carbon tetrachloride (CCl4)-induced liver fibrosis model mice, followed by the analysis of bile drainage function and donor integration in vivo. Immunohistochemical assay was examined for the regeneration of intrahepatic bile ducts in the recipient’s liver using anti-human specific keratin 19 (KRT19) antibody. Results: BA-SHED formed CFU-F, expressed MSC surface markers, and exhibited in vitro mesenchymal multipotency similar to Cont-SHED. BA-SHED showed less in vitro hepatogenic potency than Cont-SHED. Cont-SHED represented in vivo bile drainage function and KRT19-positive biliary regeneration in chronic carbon tetrachloride-induced liver fibrosis model mice. BA-SHED failed to show in vivo biliary potency and bile drainage function compared to Cont-SHED. Conclusion: These findings indicate that BA-SHED are not feasible source for BA treatment, because BA-SHED may epigenetically modify the underlying prenatal and perinatal BA environments. In conclusion, these findings suggest that BA-SHED-based studies may provide a platform for understanding the underlying molecular mechanisms of BA development and innovative novel modalities in BA research and treatment. © 2021, The Author(s).
Item Type: | Article |
---|---|
Additional Information: | Cited by: 8; All Open Access, Gold Open Access, Green Open Access |
Uncontrolled Keywords: | Animals; Biliary Atresia; Humans; Infant; Liver Cirrhosis; Liver Transplantation; Mesenchymal Stem Cells; Mice; Stem Cells; carbon tetrachloride; cytokeratin 19; animal experiment; animal model; animal tissue; Article; bile duct atresia; C57BL 6 mouse; clinical feature; colony forming unit; controlled study; deciduous tooth; human; human cell; immunohistochemistry; in vitro study; in vivo study; intrahepatic bile duct; male; mesenchymal stem cell; mouse; nonhuman; stem cell; animal; infant; liver cirrhosis; liver transplantation; mesenchymal stem cell; metabolism; pathology; stem cell |
Subjects: | R Medicine > RB Biomedical Sciences |
Divisions: | Faculty of Medicine, Public Health and Nursing > Biomedical Sciences |
Depositing User: | Sri JUNANDI |
Date Deposited: | 28 Sep 2024 02:52 |
Last Modified: | 28 Sep 2024 02:52 |
URI: | https://ir.lib.ugm.ac.id/id/eprint/4493 |